RecruitingNCT06285760

Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)

SANDI STUDY: Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure.


Sponsor

Puerta de Hierro University Hospital

Enrollment

64 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to assess the natriuretic effect of intravenous acetazolamide in patients admitted with heart failure and persistent congestion despite treatment with intravenous furosemide and sodium-glucose cotransporter type 2 (iSGLT2) inhibitors. The main question it aims to answer is whether there is a difference in natriuresis 24 hours after acetazolamide association to medical treatment recommended by the guidelines (furosemide and ISGLT2).


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is testing whether adding acetazolamide (a diuretic drug that works differently from standard water pills) helps patients hospitalized with acute heart failure remove excess fluid more effectively. **You may be eligible if...** - You were admitted to the hospital for acute heart failure with signs of fluid overload (swelling, fluid in the lungs, or fluid around the lungs) - Your heart failure blood marker (BNP or NTproBNP) is elevated at admission - You are already being treated with furosemide and an SGLT2 inhibitor but still have signs of congestion **You may NOT be eligible if...** - Your blood pressure is very low - You have taken acetazolamide in the past month - You have severely reduced kidney function or need dialysis - You have Type 1 diabetes - You are likely to need IV inotropes or other intensive heart medications during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAcetazolamide 500mg

Patients hospitalized with decompensated heart failure and fluid overload who require diuretic treatment for relieve of congestion. Standarized diuretic protocol according to guidelines will be applied. It consists of intravenous furosemide, SGLT2 inhibitors and acetazolamide if congestion persist.


Locations(1)

Julia González González

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06285760


Related Trials